Literature DB >> 24680396

A comparison of the miscarriage rate between women with and without polycystic ovarian syndrome undergoing IVF treatment.

Liu Liu1, Xiaomei Tong2, Lingying Jiang3, T C Li4, Feng Zhou5, Songying Zhang6.   

Abstract

OBJECTIVE: To investigate if patients with polycystic ovary syndrome (PCOS) who conceived via IVF treatment had a higher miscarriage rate than non-PCOS subjects after controlling for several important confounding variables relating to pregnancy loss. STUDY
DESIGN: A retrospective, observational, cohort study including a consecutive series of 564 embryo transfer cycles from PCOS patients and 7494 embryo transfer cycles from non-PCOS patients. Only the first pregnancy arising from IVF treatment was included for subsequent analysis. None of the subjects underwent ovarian diathermy or drilling prior to IVF treatment. Low dose (≤1000mg daily), short term (≤3 weeks) metformin therapy was used in 50 of the 301 PCOS subjects included in the study.
RESULTS: After controlling for the number of embryo transferred, the type of embryos transferred (fresh or frozen-thawed), and the stage of embryo development at the time of transfer, women with PCOS had a consistently higher biochemical pregnancy rate than women without PCOS (fresh single day 3 embryo transfer, 46.7% (7/15) vs. 14.5% (27/186), respectively, p<0.05; frozen-thawed single day 3 embryo transfer, 25.9% (7/27) vs. 6.1% (11/181), p<0.05; fresh double day 3 embryo transfer, 17.1% (12/70) vs. 7.6% (95/1256), p<0.05; frozen-thawed double day 3 embryo transfer, 7.9% (15/189) vs. 3.4% (66/1968), p<0.05). There was no significant difference in the clinical miscarriage rate between the two groups of subjects.
CONCLUSION: PCOS patients who conceived following IVF treatment had higher biochemical loss than women without PCOS, but the clinical miscarriage rate was no different between the two groups.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Embryo transfer; IVF; Miscarriage rate; PCOS

Mesh:

Substances:

Year:  2014        PMID: 24680396     DOI: 10.1016/j.ejogrb.2014.02.041

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  9 in total

Review 1.  Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome.

Authors:  Neil R Chappell; William E Gibbons; Chellakkan S Blesson
Journal:  Steroids       Date:  2022-02-18       Impact factor: 2.668

2.  Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome.

Authors:  Neil R Chappell; Beth Zhou; Pardis Hosseinzadeh; Amy Schutt; William E Gibbons; Chellakkan S Blesson
Journal:  F S Sci       Date:  2020-12-10

Review 3.  Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis.

Authors:  Roberto Matorras; Jose Ignacio Pijoan; Lucía Laínz; María Díaz-Nuñez; Héctor Sainz; Silvia Pérez-Fernandez; Dayana Moreira
Journal:  Arch Gynecol Obstet       Date:  2022-09-04       Impact factor: 2.493

4.  Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.

Authors:  D Fischer; C Reisenbüchler; S Rösner; J Haussmann; P Wimberger; M Goeckenjan
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-06       Impact factor: 2.915

5.  Effect of pigtail catheter application on obstetric outcomes in in vitro fertilization/intracytoplasmic sperm injection pregnancies following hyperstimulation syndrome.

Authors:  Pınar Çağlar Aytaç; Hakan Kalaycı; Selçuk Yetkinel; Didem Alkaş; Seda Yüksel Şimşek; Bülent Haydardedeoğlu; Esra Bulgan Kılıçdağ
Journal:  Turk J Obstet Gynecol       Date:  2017-06-15

6.  Prenatal androgen induced lean PCOS impairs mitochondria and mRNA profiles in oocytes.

Authors:  Neil R Chappell; Beth Zhou; Amy K Schutt; William E Gibbons; Chellakkan S Blesson
Journal:  Endocr Connect       Date:  2020-02-01       Impact factor: 3.335

7.  Pregnancy outcomes in patients with polycystic ovary syndrome who conceived after single thawed blastocyst transfer: a propensity score-matched study.

Authors:  Hui-Ying Jie; Xiu Zhou; Ming-Peng Zhao; Min Hu; Qing-Yun Mai; Can-Quan Zhou
Journal:  BMC Pregnancy Childbirth       Date:  2022-09-20       Impact factor: 3.105

8.  Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls.

Authors:  Neil Ryan Chappell; Maya Barsky; Jaimin Shah; Mary Peavey; Liubin Yang; Haleh Sangi-Haghpeykar; William Gibbons; Chellakkan Selvanesan Blesson
Journal:  F S Rep       Date:  2020-09-02

Review 9.  Complications and challenges associated with polycystic ovary syndrome: current perspectives.

Authors:  Stefano Palomba; Susanna Santagni; Angela Falbo; Giovanni Battista La Sala
Journal:  Int J Womens Health       Date:  2015-07-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.